What does Beam Therapeutics Inc. (BEAM) do?

Beam Therapeutics Inc. (BEAM) is a publicly traded company in the Healthcare sector.

What sector does BEAM operate in?

Beam Therapeutics Inc. operates in the Healthcare, specifically within the Biotechnology industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find BEAM earnings analysis?

AlphaOS publishes an earnings intelligence page for Beam Therapeutics Inc. (BEAM) covering results, guidance context, and AI-assisted analysis. See /stocks/BEAM/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BEAM

Beam Therapeutics Inc.

Healthcare · Biotechnology

$25.93Sep 22, 2026

AI confidence 62% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Beam Therapeutics Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -94% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -94% YoY in Q2 FY2026

Pipeline evidence · 0d ago

AlphaOS Signals

Upgrade to Premium

Latest earnings · Q2 2026

Full BEAM earnings analysis

Reported figures for Beam Therapeutics Inc. — research only, not investment advice.

Revenue YoY: -100.0%

Latest Intelligence

Updated September 23, 2026

What happened recently for Beam Therapeutics Inc. (BEAM) — events, not interpretation.

Event: Reported Q2 2026 revenue -100% YoY.
Also: Last session September 22, 2026 at $25.93.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Loading earnings intelligence…

Beam Therapeutics Inc. (BEAM)

Healthcare · Biotechnology

Investment Snapshot above is the primary AlphaOS analysis for Beam Therapeutics Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Biotechnology
Market cap:: $2.68B
Revenue:: $31.74M

BEAM earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Beam Therapeutics Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Themes